Vivosim
Vivosim AI helps cancer patients receive dosing that aims to improve treatment efficacy and safety. It uses proprietary AI algorithms to model patient responses and optimize dosing across treatment cycles. The platform targets hematologic cancers and is positioned as a B2B oncology tool for clinics and pharma development. Key technologies include AI, proprietary algorithms, and oncology dosing optimization. The solution aims to scale across cancer care settings to improve outcomes and safety.
Vivosim
Vivosim AI helps cancer patients receive dosing that aims to improve treatment efficacy and safety. It uses proprietary AI algorithms to model patient responses and optimize dosing across treatment cycles. The platform targets hematologic cancers and is positioned as a B2B oncology tool for clinics and pharma development. Key technologies include AI, proprietary algorithms, and oncology dosing optimization. The solution aims to scale across cancer care settings to improve outcomes and safety.